About TRANSCEND THERAPEUTICS, INC.
Transcend Therapeutics is a biopharmaceutical company focused on developing rapid-acting treatments for neuropsychiatric diseases, with a current emphasis on PTSD. The company was acquired by Otsuka Pharmaceutical and has received an FDA National Priority Voucher for its drug candidate TSND-201.
Drug development for neuropsychiatric diseasesRapid-acting neuroplastogen researchClinical trial execution (e.g., IMPACT-1 study)
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to TRANSCEND THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.